COVIDOSE: Determining infectious dose for SARS-CoV-2 and assessing contact/proximity risk

The COVIDOSE project has a goal-oriented and straightforward approach to its first and main goal: determining the infectious dose, i.e. the minimum number of SARS-CoV-2 virus particles needed to start an infection resulting in disease, achieved through coalescent analysis on population-based viral genomics sampled from Norwegian patients. Furthermore, this will be compared to samples from likely contact points in the environment to contribute to risk assessment and transmission dynamics. Lastly, an innovative outreach plan enables an open platform for our research. It draws on a small, dedicated team of specialists well placed for such a study. The team consists of highly creative,ambitious and talented researchers in established yet highly productive career stages with the ability, experience and drive to accomplish our objectives. Our work is highly visible and has been featured in Nature, Science, PNAS, Nature Communications, Nature Ecology & Evolution, among other top journals.